Trypanocidal Activity of Aziridinyl Nitrobenzamide Prodrugs

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2010-08-02

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1128/AAC.00800-10PMID 20679506PMCID PMC2944584
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human African trypanosomiasis

  2010cited by this paper
• Chagas disease in Spain, the United States and other non-endemic countries.

  2010cited by this paper
• A phase I trial of PR-104, a nitrogen mustard prodrug activated by both hypoxia and aldo-keto reductase 1C3, in patients with solid tumors

  2010cited by this paper
• Cross-Resistance to Nitro Drugs and Implications for Treatment of Human African Trypanosomiasis

  2010cited by this paper
• Image-Based High-Throughput Drug Screening Targeting the Intracellular Stage of Trypanosoma cruzi, the Agent of Chagas' Disease

  2010cited by this paper
• A Phase I/II Clinical Trial in Localized Prostate Cancer of an Adenovirus Expressing Nitroreductase with CB1984.

  2009cited by this paper
• An estimate of the burden of Chagas disease in the United States.

  2009cited by this paper
• A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1954 [correction of CB1984].

  2009cited by this paper
• Exploiting the Drug-Activating Properties of a Novel Trypanosomal Nitroreductase

  2009cited by this paper
• Design of anticancer prodrugs for reductive activation

  2009influential reference
• Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.

  2009cited by this paper
• Nifurtimox Induces Apoptosis of Neuroblastoma Cells In Vitro and In Vivo

  2009cited by this paper
• Metabolic activation of the antitumor drug 5-(Aziridin-1-yl)-2,4-dinitrobenzamide (CB1954) by NO synthases.

  2008cited by this paper
• Giardia, Entamoeba, and Trichomonas Enzymes Activate Metronidazole (Nitroreductases) and Inactivate Metronidazole (Nitroimidazole Reductases)

  2008cited by this paper
• Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication.

  2008cited by this paper
• A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes

  2008influential reference
• Kinetic and structural characterisation of Escherichia coli nitroreductase mutants showing improved efficacy for the prodrug substrate CB1954.

  2007cited by this paper
• Nifurtimox plus Eflornithine for Late-Stage Sleeping Sickness in Uganda: A Case Series

  2007cited by this paper
• A Novel Giardia lamblia Nitroreductase, GlNR1, Interacts with Nitazoxanide and Other Thiazolides

  2007cited by this paper
• Impairment of cell division of Trypanosoma cruzi epimastigotes.

  2007cited by this paper
• Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo.

  2007cited by this paper
• Three Drug Combinations for Late-Stage Trypanosoma brucei gambiense Sleeping Sickness: A Randomized Clinical Trial in Uganda

  2006cited by this paper
• The future of Chagas disease control.

  2006cited by this paper
• BMC Biotechnology BioMed Central Research article pTcINDEX: a stable tetracycline-regulated expression vector for

  2006cited by this paper
• Antitumor Activity of Nifurtimox Observed in a Patient With Neuroblastoma

  2006cited by this paper
• Aerobic 2- and 4-nitroreduction of CB 1954 by human liver.

  2005cited by this paper
• Tagging a T. brucei RRNA locus improves stable transfection efficiency and circumvents inducible expression position effects.

  2005cited by this paper
• Aziridinyldinitrobenzamides: synthesis and structure-activity relationships for activation by E. coli nitroreductase.

  2004influential reference
• 2-Amino metabolites are key mediators of CB 1954 and SN 23862 bystander effects in nitroreductase GDEPT

  2004influential reference
• The trypanosomiases.

  2003cited by this paper
• Effect of nitroreduction on the alkylating reactivity and cytotoxicity of the 2,4-dinitrobenzamide-5-aziridine CB 1954 and the corresponding nitrogen mustard SN 23862: distinct mechanisms of bioreductive activation.

  2003cited by this paper
• Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy)

  2003influential reference
• A critical review on Chagas disease chemotherapy.

  2002cited by this paper
• Evidence for Lateral Transfer of Genes Encoding Ferredoxins, Nitroreductases, NADH Oxidase, and Alcohol Dehydrogenase 3 from Anaerobic Prokaryotes to Giardialamblia and Entamoebahistolytica

  2002cited by this paper
• In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis.

  2002cited by this paper
• Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: a phase I and pharmacokinetic study of its prodrug, CB1954.

  2001cited by this paper
• Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy.

  2000cited by this paper
• A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis

  2000cited by this paper
• Application of a multi-endpoint cytotoxicity assay to the trypanocidal compounds 2-propen-1-amine derivatives and determination of their acute toxicity

  1998cited by this paper
• Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox.

  1998cited by this paper
• Molecular Basis of the Catalytic Differences among DT-diaphorase of Human, Rat, and Mouse*

  1997cited by this paper
• pRIBOTEX expression vector: a pTEX derivative for a rapid selection of Trypanosoma cruzi transfectants.

  1997cited by this paper
• Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.

  1997cited by this paper
• Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase

  1996cited by this paper
• Identification, synthesis and properties of 5-(aziridin-1-yl)-2-nitro-4-nitrosobenzamide, a novel DNA crosslinking agent derived from CB1954.

  1993cited by this paper
• A shuttle vector which facilitates the expression of transfected genes in Trypanosoma cruzi and Leishmania.

  1992cited by this paper
• The bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)--II. A comparison of an Escherichia coli nitroreductase and Walker DT diaphorase.

  1992cited by this paper
• Bioactivation of CB 1954: reaction of the active 4-hydroxylamino derivative with thioesters to form the ultimate DNA-DNA interstrand crosslinking species.

  1991cited by this paper
• Trypanosoma cruzi glycosomal glyceraldehyde‐3‐phosphate dehydrogenase does not conform to the ‘hotspot’ topogenic signal model.

  1990cited by this paper
• Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers.

  1989cited by this paper
• Genotoxicity testing of antiparasitic nitrofurans in the Drosophila wing somatic mutation and recombination test.

  1989cited by this paper
• Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease.

  1987cited by this paper
• Mutagenicity of nifurtimox and benznidazole in the Salmonella/microsome assay.

  1986cited by this paper
• Reduction of nifurtimox and nitrofurantoin to free radical metabolites by rat liver mitochondria. Evidence of an outer membrane-located nitroreductase.

  1984cited by this paper
• Generation of free radicals induced by nifurtimox in mammalian tissues.

  1981cited by this paper
• Oxygen-sensitive and -insensitive nitroreduction by Escherichia coli and rat hepatic microsomes.

  1979cited by this paper
• Chemotherapeutic properties of heterocyclic compounds: monocyclic compounds with five-membered rings.

  1973cited by this paper

• Identification of antifungal agents AR-12 and Fosmanogepix as anti-Trypanosoma cruzi drugs through an enhanced fluorogenic β-galactosidase phenotypic screening assay

  2025cites this paper
• Development of bioluminescent reporter Trypanosoma cruzi and bioassay for compound screening

  2024cites this paper
• Dissecting the interstrand crosslink DNA repair system of Trypanosoma cruzi.

  2023cites this paper
• A Multi-Species Phenotypic Screening Assay for Leishmaniasis Drug Discovery Shows That Active Compounds Display a High Degree of Species-Specificity

  2020cites this paper
• Of Drugs and Trypanosomatids: New Tools and Knowledge to Reduce Bottlenecks in Drug Discovery

  2020cites this paper
• Targeting farnesyl pyrophosphate synthase of Trypanosoma cruzi by fragment-based lead discovery

  2019cites this paper
• Deciphering the interstrand crosslink DNA repair network expressed by Trypanosoma brucei

  2019cites this paper
• Tetrasubstituted Imidazolium Salts as Potent Antiparasitic Agents against African and American Trypanosomiases

  2018cites this paper
• A Bioactive Trypanosoma cruzi Bromodomain Inhibitor from Chemically Engineered Extracts.

  2018cites this paper
• Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi

  2018cites this paper
• Efficacy and Safety of Chagas Disease Drug Therapy and Treatment Perspectives

  2018cites this paper
• Aldo‐keto reductase and alcohol dehydrogenase contribute to benznidazole natural resistance in Trypanosoma cruzi

  2017cites this paper
• Identification of Specific Inhibitors of Trypanosoma cruzi Malic Enzyme Isoforms by Target-Based HTS

  2017cites this paper
• Synthesis and biological evaluation of N-cyanoalkyl-, N-aminoalkyl-, and N-guanidinoalkyl-substituted 4-aminoquinoline derivatives as potent, selective, brain permeable antitrypanosomal agents

  2016cites this paper
• Current drug therapy and pharmaceutical challenges for Chagas disease.

  2016cites this paper
• Microbial Transformation of Nitrogen Containing Heterocycles

  2016cites this paper
• Novel drug discovery for Chagas disease

  2016cites this paper
• A New Experimental Model for Assessing Drug Efficacy against Trypanosoma cruzi Infection Based on Highly Sensitive In Vivo Imaging

  2015cites this paper
• Multicomponent reaction-based synthesis and biological evaluation of tricyclic heterofused quinolines with multi-trypanosomatid activity

  2015cites this paper
• Unravelling the role of SNM1 in the DNA repair system of Trypanosoma brucei

  2015influential citation
• Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection

  2014cites this paper
• Further insights into biological evaluation of new anti-Trypanosoma cruzi 5-nitroindazoles

  2014cites this paper
• Transformation of saturated nitrogen-containing heterocyclic compounds by microorganisms

  2014cites this paper
• Megazol and its bioisostere 4H-1,2,4-triazole: comparing the trypanocidal, cytotoxic and genotoxic activities and their in vitro and in silico interactions with the Trypanosoma brucei nitroreductase enzyme

  2014cites this paper
• Novel nitro(triazole/imidazole)-based heteroarylamides/sulfonamides as potential antitrypanosomal agents.

  2014cites this paper
• Estudo do mecanismo de resistência a compostos derivados da classe das tiossemicarbazonas em tripanosomatídeos, com ênfase na glicoproteína-P e na nitrorredutase do tipo I

  2014cites this paper
• UNIVERSITY OF SÃO PAULO SCHOOL OF PHARMACEUTICAL SCIENCES OF RIBEIRÃO PRETO Structural and functional characterization of Trypanosoma cruzi fumarate hydratase isoforms

  2014cites this paper
• Novel 3-nitro-1H-1,2,4-triazole-based piperazines and 2-amino-1,3-benzothiazoles as antichagasic agents.

  2013cites this paper
• Luminescent multiplex viability assay for Trypanosoma brucei gambiense

  2013cites this paper
• A Class of 5-Nitro-2-furancarboxylamides with Potent Trypanocidal Activity against Trypanosoma brucei in Vitro

  2013cites this paper
• Evaluating 5-Nitrofurans as Trypanocidal Agents

  2013cites this paper
• Evaluating Aziridinyl Nitrobenzamide Compounds as Leishmanicidal Prodrugs

  2013influential citation
• Pharmacokinetics of Hydroxymethylnitrofurazone, a Promising New Prodrug for Chagas' Disease Treatment

  2013cites this paper
• Selective activity of 2,4-diaryl-1,2,3,4-tetrahydroquinolines on Trypanosoma cruzi epimastigotes and amastigotes expressing β-galactosidase.

  2013cites this paper
• Novel 3-nitro-1H-1,2,4-triazole-based compounds as potential anti-Chagasic drugs: in vivo studies.

  2013cites this paper
• Non-Invasive In Vivo Study of the Trypanosoma vivax Infectious Process Consolidates the Brain Commitment in Late Infections

  2013cites this paper
• Novel 3-nitro-1H-1,2,4-triazole-based amides and sulfonamides as potential antitrypanosomal agents.

  2012cites this paper
• Instituto Oswaldo Cruz

  2012cites this paper
• Targeting the Substrate Preference of a Type I Nitroreductase To Develop Antitrypanosomal Quinone-Based Prodrugs

  2012cites this paper
• Design, synthesis, and evaluation of potential prodrugs of DFMO for reductive activation.

  2012cites this paper
• Topoisomerase-II mediated biochemical mapping of centromeres and nitroreductase mediated drug metabolism in Trypanosomatids

  2012cites this paper
• Experimental chemotherapy and approaches to drug discovery for Trypanosoma cruzi infection.

  2011cites this paper
• Novel 3-nitro-1H-1,2,4-triazole-based aliphatic and aromatic amines as anti-chagasic agents.

  2011cites this paper
• Nifurtimox Activation by Trypanosomal Type I Nitroreductases Generates Cytotoxic Nitrile Metabolites

  2011cites this paper
• Nitroaromatic pro-drug activation and resistance in the African trypanosome

  2011cites this paper
• Methodological advances in drug discovery for Chagas disease

  2011cites this paper
• Naegleria gruberi metabolism.

  2011cites this paper
• Novel Lipophilic Acetohydroxamic Acid Derivatives Based on Conformationally Constrained Spiro Carbocyclic 2,6-Diketopiperazine Scaffolds with Potent Trypanocidal Activity

  2011cites this paper
• Huprines as a new family of dual acting trypanocidal–antiplasmodial agents

  2011cites this paper
• Manuscript type: Research Article

  2009cites this paper